Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow JonesJan 10 21:06 · Ratings

Biomea Fusion Price Target Maintained With a $128.00/Share by D. Boral Capital

Dow JonesJan 10 21:06 · Ratings

Barclays Maintains Biomea Fusion(BMEA.US) With Hold Rating, Maintains Target Price $11

Futu NewsJan 9 17:34 · Ratings

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Biomea Fusion (BMEA) and Solid Biosciences (SLDB)

TipRanksJan 9 17:10 · Ratings

Scotiabank Maintains Biomea Fusion(BMEA.US) With Buy Rating, Cuts Target Price to $30

Futu NewsJan 8 23:33 · Ratings

Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study

GlobeNewswireJan 7 22:00